Zeria To Test Old Cancer Vaccine For End-Stage Cervical Cancer
This article was originally published in PharmAsia News
Executive Summary
Zeria Pharmaceutical plans clinical trials in Japan, South Korea and Taiwan next year of a decades-old Japan cancer vaccine, using a higher concentration of it as a treatment for end-stage cervical cancer.